Recurrent endogenous candidal endophthalmitis in a premature infant

J AAPOS. 2001 Feb;5(1):50-1. doi: 10.1067/mpa.2001.111136.

Abstract

Endogenous Candida endophthalmitis resulting from candidemia in low-birth-weight infants usually occurs as a retinochoroiditis, which is effectively treated with systemic antifungal agents. We report a case of Candida endophthalmitis that recurred 4 months after completion of systemic antifungal therapy. The recurrent Candida infection affected primarily the iris and lens, rather than the retina and choroid. Vitrectomy was required for diagnosis and treatment.

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / therapeutic use
  • Betaxolol / therapeutic use
  • Candida albicans / isolation & purification*
  • Candidiasis* / diagnosis
  • Candidiasis* / drug therapy
  • Candidiasis* / microbiology
  • Drug Therapy, Combination / therapeutic use
  • Endophthalmitis / diagnosis
  • Endophthalmitis / drug therapy
  • Endophthalmitis / microbiology*
  • Eye Infections, Fungal* / diagnosis
  • Eye Infections, Fungal* / drug therapy
  • Eye Infections, Fungal* / microbiology
  • Female
  • Fluorouracil / therapeutic use
  • Humans
  • Infant, Newborn
  • Infant, Premature*
  • Lens, Crystalline / microbiology
  • Lens, Crystalline / surgery
  • Microbial Sensitivity Tests
  • Prednisolone / analogs & derivatives*
  • Prednisolone / therapeutic use
  • Recurrence
  • Vitrectomy
  • Vitreous Body / microbiology

Substances

  • Amphotericin B
  • prednisolone acetate
  • Prednisolone
  • Betaxolol
  • Fluorouracil